miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells

被引:231
作者
Lal, Ashish [1 ,2 ]
Pan, Yunfeng [3 ,4 ]
Navarro, Francisco [1 ,2 ]
Dykxhoorn, Derek M. [1 ,2 ]
Moreau, Lisa [3 ,4 ]
Meire, Eti [5 ]
Bentwich, Zvi [5 ]
Lieberman, Judy [1 ,2 ]
Chowdhury, Dipanjan [3 ,4 ]
机构
[1] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA
[5] Rosetta Genom, Rehovot, Israel
基金
美国国家卫生研究院;
关键词
EXPRESSION; MICRORNAS; PROLIFERATION; PROTEIN; RNA;
D O I
10.1038/nsmb.1589
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Terminally differentiated cells have a reduced capacity to repair double-stranded breaks, but the molecular mechanism behind this downregulation is unclear. Here we find that miR-24 is upregulated during postmitotic differentiation of hematopoietic cell lines and regulates the histone variant H2AX, a protein that has a key role in the double-stranded break response. We show that the H2AX 3' untranslated region contains conserved miR-24 binding sites that are indeed regulated by miR-24. During terminal differentiation, both H2AX mRNA and protein levels are substantially reduced by miR-24 upregulation in in vitro differentiated cells; similar diminished levels are found in primary human blood cells. miR-24-mediated suppression of H2AX renders cells hypersensitive to gamma-irradiation and genotoxic drugs, a phenotype that is fully rescued by overexpression of miR-24-insensitive H2AX. Therefore, miR-24 upregulation in postreplicative cells reduces H2AX and makes them vulnerable to DNA damage.
引用
收藏
页码:492 / 498
页数:7
相关论文
共 25 条
[1]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]   MicroRNA expression detected by oligonucleotide microarrays: System establishment and expression profiling in human tissues [J].
Barad, O ;
Meiri, E ;
Avniel, A ;
Aharonov, R ;
Barzilai, A ;
Bentwich, I ;
Einav, U ;
Glad, S ;
Hurban, P ;
Karov, Y ;
Lobenhofer, EK ;
Sharon, E ;
Shiboleth, YM ;
Shtutman, M ;
Bentwich, Z ;
Einat, P .
GENOME RESEARCH, 2004, 14 (12) :2486-2494
[3]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors [J].
Bassing, CH ;
Suh, H ;
Ferguson, DO ;
Chua, KF ;
Manis, J ;
Eckersdorff, M ;
Gleason, M ;
Bronson, R ;
Lee, C ;
Alt, FW .
CELL, 2003, 114 (03) :359-370
[6]   DNp73α protects myogenic cells from apoptosis [J].
Belloni, L. ;
Moretti, F. ;
Merlo, P. ;
Damalas, A. ;
Costanzo, A. ;
Blandino, G. ;
Levrero, M. .
ONCOGENE, 2006, 25 (25) :3606-3612
[7]   MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias [J].
Calin, GA ;
Liu, CG ;
Sevignani, C ;
Ferracin, M ;
Felli, N ;
Dumitru, CD ;
Shimizu, M ;
Cimmino, A ;
Zupo, S ;
Dono, M ;
Dell'Aquila, ML ;
Alder, H ;
Rassenti, L ;
Kipps, TJ ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11755-11760
[8]   H2AX haploinsufficiency modifies genomic stability and tumor susceptibility [J].
Celeste, A ;
Difilippantonio, S ;
Difilippantonio, MJ ;
Fernandez-Capetillo, O ;
Pilch, DR ;
Sedelnikova, OA ;
Eckhaus, M ;
Ried, T ;
Bonner, WM ;
Nussenzweig, A .
CELL, 2003, 114 (03) :371-383
[9]   H2AX: the histone guardian of the genome [J].
Fernandez-Capetillo, O ;
Lee, A ;
Nussenzweig, M ;
Nussenzweig, A .
DNA REPAIR, 2004, 3 (8-9) :959-967
[10]  
Lukas C, 2001, CANCER RES, V61, P4990